Literature DB >> 15613423

Quantitative assessment of glucose transport in human skeletal muscle: dynamic positron emission tomography imaging of [O-methyl-11C]3-O-methyl-D-glucose.

Alessandra Bertoldo1, Julie Price, Chet Mathis, Scott Mason, Daniel Holt, Carol Kelley, Claudio Cobelli, David E Kelley.   

Abstract

Insulin-stimulated glucose transport in skeletal muscle is regarded as a key determinant of insulin sensitivity, yet isolation of this step for quantification in human studies is a methodological challenge. One notable approach is physiological modeling of dynamic positron emission tomography (PET) imaging using 2-[18-fluoro]2-deoxyglucose ([(18)F]FDG); however, this has a potential limitation in that deoxyglucose undergoes phosphorylation subsequent to transport, complicating separate estimations of these steps. In the current study we explored the use of dynamic PET imaging of [(11)C]3-O-methylglucose ([(11)C]3-OMG), a glucose analog that is limited to bidirectional glucose transport. Seventeen lean healthy volunteers with normal insulin sensitivity participated; eight had imaging during basal conditions, and nine had imaging during euglycemic insulin infusion at 30 mU/min.m(2). Dynamic PET imaging of calf muscles was conducted for 90 min after the injection of [(11)C]3-OMG. Spectral analysis of tissue activity indicated that a model configuration of two reversible compartments gave the strongest statistical fit to the kinetic pattern. Accordingly, and consistent with the structure of a model previously used for [(18)F]FDG, a two-compartment model was applied. Consistent with prior [(18)F]FDG findings, insulin was found to have minimal effect on the rate constant for movement of [(11)C]3-OMG from plasma to tissue interstitium. However, during insulin infusion, a robust and highly significant increase was observed in the kinetics of inward glucose transport; this and the estimated tissue distribution volume for [(11)C]3-OMG increased 6-fold compared with basal conditions. We conclude that dynamic PET imaging of [(11)C]3-OMG offers a novel quantitative approach that is both chemically specific and tissue specific for in vivo assessment of glucose transport in human skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15613423     DOI: 10.1210/jc.2004-1092

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.

Authors:  Jason M Ng; Alessandra Bertoldo; Davneet S Minhas; Nicole L Helbling; Paul M Coen; Julie C Price; Claudio Cobelli; David E Kelley; Bret H Goodpaster
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport.

Authors:  Pascale Perret; Lotfi Slimani; Arnaud Briat; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-15       Impact factor: 9.236

Review 3.  Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.

Authors:  Eugene J Barrett; Hong Wang; Charles T Upchurch; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

4.  Analysis of metabolism of 6FDG: a PET glucose transport tracer.

Authors:  Raymond F Muzic; Visvanathan Chandramouli; Hsuan-Ming Huang; Chunying Wu; Yanming Wang; Faramarz Ismail-Beigi
Journal:  Nucl Med Biol       Date:  2011-03-03       Impact factor: 2.408

5.  Uptake of 18F-labeled 6-fluoro-6-deoxy-D-glucose by skeletal muscle is responsive to insulin stimulation.

Authors:  Chandra Spring-Robinson; Visvanathan Chandramouli; William C Schumann; Peter F Faulhaber; Yanming Wang; Chunying Wu; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

6.  In vivo assessment of cardiac insulin resistance by nuclear probes using an iodinated tracer of glucose transport.

Authors:  Arnaud Briat; Lotfi Slimani; Pascale Perret; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

7.  Preclinical and clinical evaluation of a new method to assess cardiac insulin resistance using nuclear imaging.

Authors:  Pascale Perret; Lotfi Slimani; Gilles Barone-Rochette; Julien Vollaire; Arnaud Briat; Mitra Ahmadi; Marion Henri; Marie-Dominique Desruet; Romain Clerc; Alexis Broisat; Laurent Riou; François Boucher; Frédérique Frouin; Loïc Djaileb; Alex Calizzano; Gérald Vanzetto; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2021-01-27       Impact factor: 3.872

Review 8.  Spectral Analysis of Dynamic PET Studies: A Review of 20 Years of Method Developments and Applications.

Authors:  Mattia Veronese; Gaia Rizzo; Alessandra Bertoldo; Federico E Turkheimer
Journal:  Comput Math Methods Med       Date:  2016-12-05       Impact factor: 2.238

Review 9.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

10.  Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 Diabetes: studies with dynamic PET imaging.

Authors:  Bret H Goodpaster; Alessandra Bertoldo; Jason M Ng; Koichiro Azuma; R Richard Pencek; Carol Kelley; Julie C Price; Claudio Cobelli; David E Kelley
Journal:  Diabetes       Date:  2013-11-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.